57 related articles for article (PubMed ID: 14700405)
21. Neutropenic patients and their infectious complications at a University Hospital.
Lima SS; França MS; Godoi CC; Martinho GH; de Jesus LA; Romanelli RM; Clemente WT
Rev Bras Hematol Hemoter; 2013; 35(1):18-22. PubMed ID: 23580879
[TBL] [Abstract][Full Text] [Related]
22. Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study.
Huoi C; Vanhems P; Nicolle MC; Michallet M; Bénet T
PLoS One; 2013; 8(3):e58121. PubMed ID: 23472145
[TBL] [Abstract][Full Text] [Related]
23. Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.
Tumbarello M; Trecarichi EM; Caira M; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Spadea A; Busca A; Vianelli N; Spanu T; Pagano L;
PLoS One; 2012; 7(12):e51612. PubMed ID: 23272123
[TBL] [Abstract][Full Text] [Related]
24. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
Liss BJ; Vehreschild JJ; Cornely OA; Hallek M; Fätkenheuer G; Wisplinghoff H; Seifert H; Vehreschild MJ
Infection; 2012 Dec; 40(6):613-9. PubMed ID: 22665143
[TBL] [Abstract][Full Text] [Related]
25. Costs of hospital-acquired infection and transferability of the estimates: a systematic review.
Fukuda H; Lee J; Imanaka Y
Infection; 2011 Jun; 39(3):185-99. PubMed ID: 21424853
[TBL] [Abstract][Full Text] [Related]
26. Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection.
Camargo MR; Venturini J; Vilani-Moreno FR; Arruda MS
BMC Infect Dis; 2009 Jun; 9():98. PubMed ID: 19534779
[TBL] [Abstract][Full Text] [Related]
27. Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients.
Ashour HM; El-Sharif A
J Transl Med; 2009 Feb; 7():14. PubMed ID: 19228413
[TBL] [Abstract][Full Text] [Related]
28. Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices.
Worth LJ; Seymour JF; Slavin MA
Support Care Cancer; 2009 Jul; 17(7):811-8. PubMed ID: 19096883
[TBL] [Abstract][Full Text] [Related]
29. Dynamical system analysis of Staphylococcus epidermidis bloodstream infection.
Chung HM; Cartwright MM; Bortz DM; Jackson TL; Younger JG
Shock; 2008 Nov; 30(5):518-26. PubMed ID: 18317411
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections.
Velasco E; Byington R; Martins CA; Schirmer M; Dias LM; Gonçalves VM
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):1-7. PubMed ID: 16424972
[TBL] [Abstract][Full Text] [Related]
31. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
32. Bloodstream infections in patients with solid tumors.
Gudiol C; Aguado JM; Carratalà J
Virulence; 2016 Apr; 7(3):298-308. PubMed ID: 26787095
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
[TBL] [Abstract][Full Text] [Related]
34. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
Pittet D; Tarara D; Wenzel RP
JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
[TBL] [Abstract][Full Text] [Related]
35. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
36. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
